Retracted COVID-19 studies expose holes in vetting of data firms
The US FDA now allows data gathered outside of clinical trials to be considered in its reviews of new drugs, providing another boost to the healthcare analytics industry
A laboratory technician is seen at the Inselspital Universitaetsspital Bern university hospital during researches for a vaccine against the coronavirus disease (COVID-19) in Bern, Switzerland April 22, 2020(photo credit: REUTERS)ByREUTERS
